NRG delivers 10 patient doses of Lutetium-177 Last week, NRG has delivered lutetium for the first time to an academic hospital and two pharmaceutical parties this month. Sander de Groot, program manager medical isotopes at NRG: “This isotope offers a great perspective for the effective treatment of various cancer indications and with limited side effects.…
Petten HFR Will Produce Medical Isotopes Only With LEU The High Flux Reactor in Petten, operated by NRG, from now on produces only medical isotopes with low-enriched uranium (LEU). Until recently, the productions for NRG’s Belgian partner IRE were still based on high-enriched uranium, because IRE could not fully process low-enriched uranium. But now IRE…
IAEA Launches A New Research Project On Dosimetry In Diagnostic Radiology The IAEA has launched a five-year Coordinated Research Project (CRP) to improve the accuracy of dosimetry in diagnostic and interventional radiology. The new CRP starting this year seeks to provide data needed for the update of the IAEA Technical Reports Series (TRS) No. 457…
SCK CEN And Quirem Medical Start Producing Ho-166 Microspheres At BR2 Reactor SCK CEN and Quirem Medical announce the first production of holmium-166 microspheres for patient use at the BR2 reactor in Mol, Belgium. A first clinical QuiremSpheres® patient procedure took place with radioactive holmium-166 microspheres, an innovative product for treating liver cancer patients. QuiremSpheres is…
How radiation can save lives Associazione Italiana Nucleare interviewed Dr. Riccardo Bevilacqua, an Italian nuclear physicist who dedicates himself, his work and passion to radiological safety and protection, so showing how radiation can have several positive purposes and, above all, can save lives. The interview has been translated into English by ENS. Associazione Italiana Nucleare…
SCK CEN And IBA Cooperate To Enable The Production Of Actinium-225 SCK CEN – Belgian Nuclear Research Center (ENS Corporate Member) and IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announced a strategic R&D partnership to enable the production of Actinium-225 (225Ac), a novel radioisotope which has significant potential in…
HFR 60th Anniversary And The Rising Demand For Radiopharmaceuticals The demand for medical treatments is rising sharply, partly due to the increased incidence of cancer. In the past year, 115,000 new cases of cancer have been diagnosed in the Netherlands, 13,000 of which prostate cancer. Consequently, NRG|PALLAS is seeing an increase in the demand for…
Westinghouse and EDF To Collaborate To Produce Cobalt-60 Radioisotope During the last World Nuclear Exhibition, Westinghouse Electric Company and EDF (both ENS Corporate Members) signed a Memorandum of Understanding to produce Cobalt-60 radioisotope in select Pressurized Water Reactors (PWR) owned and operated by EDF in France. Cobalt-60 plays a critical role in the safety of medical…
Framatome and Exelon Signed A MoU To Strengthen Cobalt-60 Production Framatome (ENS Corporate Member) and Exelon Generation recently announced the signature of a Memorandum of Understanding to develop solutions to produce Cobalt-60 in Pressurized Water Reactors (PWR) operated by Exelon Generation in the US. Cobalt-60 is a radioisotope produced in nuclear reactors out of natural…
Radioisotopes for Life // Ensuring European Supply – Stakeholders and Opportunities The European Nuclear Society organised the webinar “Radioisotopes for life. Ensuring European supply – Stakeholders and opportunities”, in collaboration with Euratom Supply Agency, SCK CEN (both ENS Members), PALLAS and the EU Commission DG ENER. Speakers, moderated by Kristoff Muylle (former President of the…